040-000-520 Lansoprazole
| Type | Active Pharmaceutical ingredient |
| CAS No. | 103577-45-3 |
| Chemical Formula | C16H14F3N3O2S |
| Appearance | white powder |
| Packaging | 1g, 5g, 50g, 1kg |
| Assay | ≥98% |
| Related Products | Valsartan, Irbesartan, Olmesartan Medoxomil |
related products: Esomeprazole Magnesium, Mogroside Powder
Description
Lansoprazole Introduction
Lansoprazole is a new type of drug that inhibits gastric acid secretion. It has a significant inhibitory effect on basal gastric acid secretion and gastric acid secretion caused by all stimuli. It’s acid inhibitory effect is significantly better than that of H2 receptor blockers.
Lansoprazole Specification
| Appearance | white powder |
| Melting Point | 178-182℃ |
| Boiling Point | 555.8±60.0℃ |
| Density | 1.50±0.1 g/cm3 |
| Storage Condition | 2-8℃ |
| Content | 98.0% |
| Packaging | 1g, 5g, 50g, 1kg |
Lansoprazole Applications
Lansoprazole is clinically used for the treatment of duodenal ulcer, gastric ulcer, anastomotic ulcer, and reflux esophagitis, with remarkable curative effect.
Lansoprazole Side Effects:
-
Allergic Reactions: Occasionally, rash, itching, and other symptoms may occur.
-
Hematologic System: Rare cases of anemia, leukopenia, and eosinophilia have been reported. Thrombocytopenia occurs very rarely.
-
Digestive System: Occasionally, constipation, diarrhea, thirst, and abdominal distension may occur. In some cases, elevated levels of ALT, AST, ALP, LDH, and γ-GTP have been observed. Close monitoring is required, and if abnormalities are detected, appropriate measures such as discontinuation of the medication should be taken.
-
Nervous System: Occasionally, headache and drowsiness may occur. Insomnia and dizziness are very rare.
-
Other: Occasional reports of fever, increased total cholesterol, and elevated uric acid levels.
